CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
ESHAP Salvage Therapy for Refractory and Relapsed Non-Hodgkin's Lymphoma: A Single Center Experience
Sang Hyoung Park, Shin Kim, Ok Bae Ko, Ja Eun Koo, Danbi Lee, Yong Pil Jeong, Jooryung Huh, Sung-Bae Kim, Sang We Kim, Jae-Lyun Lee, Cheolwon Suh
Korean J Intern Med. 2006;21(3):159-164.   Published online 2006 September 30    DOI: https://doi.org/10.3904/kjim.2006.21.3.159

Excel Download

Definitive Salvage Chemotherapy for the Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma, A Single Center Experience
Clinical Lymphoma Myeloma and Leukemia. 2019;19:S247   Crossref logo
Link1 Link2

ESHAP Salvage Therapy for Refractory and Relapsed Non-Hodgkin's Lymphoma: A Single Center Experience
The Korean Journal of Internal Medicine. 2006;21(3):159   Crossref logo
Link1 Link2 Link3

Efficacy of Gemcitabine as Salvage Therapy for Relapsed and Refractory Aggressive Non-Hodgkin Lymphoma
Acta Haematologica. 2019;141(2):84-90   Crossref logo
Link1 Link2

Current Real-Life Results and Future Options of Gemcitabine-Based Salvage Therapy for Relapsed or Refractory Non-Hodgkin Lymphoma
Acta Haematologica. 2019;141(3):187-188   Crossref logo
Link1 Link2

Salvage therapy with PROMACE in relapsed non-Hodgkin malignant lymphoma
European Journal of Haematology. 2009;46(2):123-124   Crossref logo
Link1

Definitive salvage chemotherapy for the treatment of refractory/relapsed non-Hodgkin lymphoma, a single center experience
Alexandria Journal of Medicine. 2018;54(4):679-683   Crossref logo
Link1 Link2 Link3

Rituximab and ESHAP as Second-line Therapy for Relapsed or Primary Refractory Diffuse Large B Cell Lymphoma: The Experience of a Single Center in Korea
The Korean Journal of Hematology. 2007;42(4):309   Crossref logo
Link1 Link2 Link3

Efficacy and Safety of Rituximab Combined with ESHAP Chemotherapy for the Treatment of Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Clinical Lymphoma and Myeloma. 2007;7(6):406-412   Crossref logo
Link1 Link2

ESHAP Salvage Therapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
Journal of Korean Medical Science. 2002;17(5):621   Crossref logo
Link1 Link2 Link3

Brentuximab vedotin and bendamustine as salvage therapy for primary refractory or relapsed Hodgkin lymphoma: A multicentre experience of the Polish lymphoma research group
Hematological Oncology. 2017;35:319-320   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.